In the current study, we employed a label-free proteomic analysis of the secretome of HCC cells and identified a close relationship between the secreted protein PRSS35, NETs and HCC prognosis, suggesting its potential value as a biomarker for screening early-stage HCC as well as a potential candidate target for HCC therapeutic strategies. This evidence concerns the gene PRSS35 and hepatocellular carcinoma.